Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
Antibody-drug conjugates (ADCs) are a potential and promising therapy for a wide variety of cancers, including breast cancer. ADC-based drugs represent a rapidly growing field of breast cancer therapy. Various ADC drug therapies have progressed over the past decade and have generated diverse opportu...
Saved in:
Main Authors: | Md Abdus Subhan (Author), Vladimir P. Torchilin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer
by: Md Abdus Subhan, et al.
Published: (2023) -
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
by: Md Abdus Subhan, et al.
Published: (2023) -
Advances in the study of marketed antibody-drug Conjugates (ADCs) for the treatment of breast cancer
by: Yan Liang, et al.
Published: (2024) -
Antibody-drug conjugates for cancer therapy
by: Anna Grzywa
Published: (2021) -
Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy
by: Antonello Pinto, et al.
Published: (2024)